// App-Quantinova.ai

194 : Patient survey evaluating available pharmacological therapies used to treat severe Raynaud’s phenomenon

Researchers

Presenter

  • Amaani Hussain

Principal Investigators

  • Bridget Griffiths

Medical Centers

  • Rheumatology Department, Freeman Hospital, Newcastle-Upon-Tyne, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Raynaud syndrome

Biomarkers

  • N/A

Drug/Treatment

  • Epoprostenol

  • Sildenafil citrate

  • Bosentan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved